GSK3B and neoplasm: Our data showing that Sirt7 expression was decreased during tumor progression (Supplementary Figs. 8a and 10) suggest that the GSK3β–SIRT7 axis might be hijacked by oncogenic signaling to facilitate tumor initiation and malignancy.